Prostate Cancer - Global Market Outlook (2017-2026)

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Prostate Cancer Market, By Type
5.1 Introduction
5.2 Hormone Sensitive
5.3 Hormone Refractory

6 Global Prostate Cancer Market, By Therapy
6.1 Introduction
6.2 Focal Therapies
6.3 Biologic Therapy
6.4 Cryosurgery
6.5 Immunotherapy
6.5.1 Vaccines
6.6 Therapeutic Vaccines
6.6.1 Provenge (Sipuleucel-T)
6.7 Radiation Therapy
6.7.1 External Beam
6.7.1.1 Stereotactic Body
6.7.1.2 Proton Beam
6.7.1.3 Intensity Modulated
6.7.1.4 3D Conformal
6.7.2 Brachytherapy
6.7.2.1 Temporary
6.7.2.2 Permanent
6.8 Chemotherapy
6.8.1 Vinorelbine
6.8.2 Vinblastine
6.8.3 Taxotere (Docetaxel)
6.8.4 Taxanes
6.8.5 Jevtana (Cabazitaxel)
6.8.6 Etoposide
6.8.7 Cytotoxic Drugs
6.8.8 Carboplatin
6.8.9 Antimetabolites
6.8.10 Anthracyclines
6.8.11 Alkylating Agents
6.9 Surgery
6.9.1 Trans Urethral Resection (TUR)
6.9.2 Radical Prostatectomy
6.9.3 Orchidectomy
6.10 Targeted Therapy
6.10.1 Tyrosine Kinase Inhibitors
6.10.2 Signal Transduction Inhibitor
6.10.3 Monoclonal Antibodies
6.10.4 Apoptosis Inducing Drugs
6.10.5 Angiogenesis Inhibitor
6.11 Bone Metastasis
6.11.1 Zometa (Zoledronic Acid)
6.11.2 Xofigo (Radium 223 Dichloride)
6.11.3 Xgeva (Denosumab)
6.11.4 Alpharadin
6.12 Hormonal Therapy
6.12.1 Aromatase Inhibitors
6.12.2 Estrogen-Receptor Modulators (Serms)
6.12.3 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
6.12.3.1 Lupron
6.12.3.2 Zoladex
6.12.3.3 Decapeptyl
6.12.3.4 Eligard
6.12.3.5 Vantas
6.12.3.6 Leuplin
6.12.3.7 Trelstar (Triptorelin Pamoate)
6.12.3.8 Firmagon (Degarelix)
6.12.3.9 Casodex (Bicalutamide)
6.12.4 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
6.12.4.1 Zytiga
6.12.4.2 Gonax
6.12.4.3 Xtandi (Enzalutamide)
6.12.5 Anti-Androgens
6.12.5.1 Casodex
6.12.5.2 Xtandi or MDV3100
6.12.5.3 Xtandi US or MDV3100
6.12.6 Other Hormonal Therapies

7 Global Prostate Cancer Market, By Diagnostic Technique
7.1 Introduction
7.2 Prostate Specific Antigen Test (PSA)
7.3 Digital Rectal Exam (DRE)

8 Global Prostate Cancer Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Pharmacies
8.5 Specialty Clinics
8.6 Other End Users

9 Global Prostate Cancer Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Astellas, Inc.
11.2 AstraZeneca plc
11.3 Bristol Myers Squibb (BMS)
11.4 Johnson & Johnson
11.5 NOVARTIS
11.6 Sanofi S.A
11.7 TOLMAR Inc.
11.8 Tokai Pharmaceuticals
11.9 Progenics Pharmaceuticals Inc.
11.10 OncoGenex Pharmaceuticals Inc.
11.11 OncBioMune Pharmaceuticals Inc.
11.12 Endo Pharmaceuticals
11.13 Bayer Pharma AG

List of Tables
1 Global Prostate Cancer Market Outlook, By Region (2016-2026) (US $MN)
2 Global Prostate Cancer Market Outlook, By Type (2016-2026) (US $MN)
3 Global Prostate Cancer Market Outlook, By Hormone Sensitive (2016-2026) (US $MN)
4 Global Prostate Cancer Market Outlook, By Hormone Refractory (2016-2026) (US $MN)
5 Global Prostate Cancer Market Outlook, By Therapy (2016-2026) (US $MN)
6 Global Prostate Cancer Market Outlook, By Focal Therapies (2016-2026) (US $MN)
7 Global Prostate Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
8 Global Prostate Cancer Market Outlook, By Cryosurgery (2016-2026) (US $MN)
9 Global Prostate Cancer Market Outlook, By Immunotherapy (2016-2026) (US $MN)
10 Global Prostate Cancer Market Outlook, By Vaccines (2016-2026) (US $MN)
11 Global Prostate Cancer Market Outlook, By Therapeutic Vaccines (2016-2026) (US $MN)
12 Global Prostate Cancer Market Outlook, By Provenge (Sipuleucel-T) (2016-2026) (US $MN)
13 Global Prostate Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
14 Global Prostate Cancer Market Outlook, By External Beam (2016-2026) (US $MN)
15 Global Prostate Cancer Market Outlook, By Brachytherapy (2016-2026) (US $MN)
16 Global Prostate Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
17 Global Prostate Cancer Market Outlook, By Vinorelbine (2016-2026) (US $MN)
18 Global Prostate Cancer Market Outlook, By Vinblastine (2016-2026) (US $MN)
19 Global Prostate Cancer Market Outlook, By Taxotere (Docetaxel) (2016-2026) (US $MN)
20 Global Prostate Cancer Market Outlook, By Taxanes (2016-2026) (US $MN)
21 Global Prostate Cancer Market Outlook, By Jevtana (Cabazitaxel) (2016-2026) (US $MN)
22 Global Prostate Cancer Market Outlook, By Etoposide (2016-2026) (US $MN)
23 Global Prostate Cancer Market Outlook, By Cytotoxic Drugs (2016-2026) (US $MN)
24 Global Prostate Cancer Market Outlook, By Carboplatin (2016-2026) (US $MN)
25 Global Prostate Cancer Market Outlook, By Antimetabolites (2016-2026) (US $MN)
26 Global Prostate Cancer Market Outlook, By Anthracyclines (2016-2026) (US $MN)
27 Global Prostate Cancer Market Outlook, By Alkylating Agents (2016-2026) (US $MN)
28 Global Prostate Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
29 Global Prostate Cancer Market Outlook, By Trans Urethral Resection (TUR) (2016-2026) (US $MN)
30 Global Prostate Cancer Market Outlook, By Radical Prostatectomy (2016-2026) (US $MN)
31 Global Prostate Cancer Market Outlook, By Orchidectomy (2016-2026) (US $MN)
32 Global Prostate Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
33 Global Prostate Cancer Market Outlook, By Tyrosine Kinase Inhibitors (2016-2026) (US $MN)
34 Global Prostate Cancer Market Outlook, By Signal Transduction Inhibitor (2016-2026) (US $MN)
35 Global Prostate Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) (US $MN)
36 Global Prostate Cancer Market Outlook, By Apoptosis Inducing Drugs (2016-2026) (US $MN)
37 Global Prostate Cancer Market Outlook, By Angiogenesis Inhibitor (2016-2026) (US $MN)
38 Global Prostate Cancer Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
39 Global Prostate Cancer Market Outlook, By Zometa (Zoledronic Acid) (2016-2026) (US $MN)
40 Global Prostate Cancer Market Outlook, By Xofigo (Radium 223 Dichloride) (2016-2026) (US $MN)
41 Global Prostate Cancer Market Outlook, By Xgeva (Denosumab) (2016-2026) (US $MN)
42 Global Prostate Cancer Market Outlook, By Alpharadin (2016-2026) (US $MN)
43 Global Prostate Cancer Market Outlook, By Hormonal Therapy (2016-2026) (US $MN)
44 Global Prostate Cancer Market Outlook, By Aromatase Inhibitors (2016-2026) (US $MN)
45 Global Prostate Cancer Market Outlook, By Estrogen-Receptor Modulators (Serms) (2016-2026) (US $MN)
46 Global Prostate Cancer Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2016-2026) (US $MN)
47 Global Prostate Cancer Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2016-2026) (US $MN)
48 Global Prostate Cancer Market Outlook, By Anti-Androgens (2016-2026) (US $MN)
49 Global Prostate Cancer Market Outlook, By Other Hormonal Therapies (2016-2026) (US $MN)
50 Global Prostate Cancer Market Outlook, By Diagnostic Technique (2016-2026) (US $MN)
51 Global Prostate Cancer Market Outlook, By Prostate Specific Antigen Test (PSA) (2016-2026) (US $MN)
52 Global Prostate Cancer Market Outlook, By Digital Rectal Exam (DRE) (2016-2026) (US $MN)
53 Global Prostate Cancer Market Outlook, By End User (2016-2026) (US $MN)
54 Global Prostate Cancer Market Outlook, By Ambulatory Surgical Centers (2016-2026) (US $MN)
55 Global Prostate Cancer Market Outlook, By Hospitals (2016-2026) (US $MN)
56 Global Prostate Cancer Market Outlook, By Pharmacies (2016-2026) (US $MN)
57 Global Prostate Cancer Market Outlook, By Specialty Clinics (2016-2026) (US $MN)
58 Global Prostate Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)

NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.

Report Details

  • Report Code:24815
  • Category:Healthcare
  • No. of Pages:155
  • Format:PDF/PPT/Excel
  • Published:September 2019
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers